Detailed answers about AFI CLINICAL DEVELOPMENT LTD, including incorporation, status, business activity, and accounts information.
When was AFI CLINICAL DEVELOPMENT LTD founded?
AFI CLINICAL DEVELOPMENT LTD was officially incorporated on 28 December 2022 and is registered under company number 14558665. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is AFI CLINICAL DEVELOPMENT LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of AFI CLINICAL DEVELOPMENT LTD?
AFI CLINICAL DEVELOPMENT LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does AFI CLINICAL DEVELOPMENT LTD do?
AFI CLINICAL DEVELOPMENT LTD operates in the following sectors: 72110 - Research and experimental development on biotechnology, 72190 - Other research and experimental development on natural sciences and engineering. These SIC codes provide insight into the company's business activities and industry focus.
What is AFI CLINICAL DEVELOPMENT LTD's registered address?
The registered office address of AFI CLINICAL DEVELOPMENT LTD is C/O BMD, FOX COURT, 14 GRAY'S INN ROAD, LONDON, UNITED KINGDOM, WC1X 8HN. This is the official address filed with Companies House for legal and statutory correspondence.
Is AFI CLINICAL DEVELOPMENT LTD financially stable?
The most recent accounts for AFI CLINICAL DEVELOPMENT LTD were made up to 30 November 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 August 2027.